カテゴリ： Infiniti Research TechNavio, 世界, 医療/バイオ

世界のジェネリック医薬品市場2023～2027：経口、注射、座薬(外用)、吸入器

■ 英語タイトル：Global Generic drugs Market 2023-2027

調査会社Technavio社が発行したリサーチレポート（データ管理コード：IRTNTR44584-23）■ 発行会社/調査会社：Technavio
■ 商品コード：IRTNTR44584-23
■ 発行日：2022年12月30日
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：167
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のジェネリック医薬品市場2023～2027：経口、注射、座薬(外用)、吸入器]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Technavio社発行の当調査レポートは、世界のジェネリック医薬品市場規模が2022年から2027年まで年平均7.11%成長し、1762.5億ドルに達すると予測しています。当レポートでは、ジェネリック医薬品の世界市場について総合的に調査・分析を行い、エグゼクティブサマリー、市場状況、市場規模、過去の市場規模、ファイブフォース分析、投与方法別（経口、注射、座薬(外用)、吸入器）分析、種類別（低分子ジェネリック医薬品、バイオシミラー）分析、顧客状況、地域別状況（北米、ヨーロッパ、アジア太平洋、アメリカ、ドイツ、中国、イギリス、インド、その他地域）分析、推進要因・課題・動向、企業状況、企業分析などの内容をまとめております。なお、参入企業情報として、Abbott Laboratories、Amgen Inc.、Aurobindo Pharma Ltd.、Baxter International Inc.、Biocon Ltd.、Dr Reddys Laboratories Ltd.、Eli Lilly and Co.、Endo International Plc、Fresenius SE and Co. KGaA、GlaxoSmithKline Plc、Merck and Co. Inc.、Novartis AG、Pfizer Inc.、Sanofi SA、Teva Pharmaceutical Industries Ltd.、Viatris Inc.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・過去の市場規模
・ファイブフォース分析

・世界のジェネリック医薬品市場規模：投与方法別
- 経口投与の市場規模
- 注射投与の市場規模
- 座薬(外用)投与の市場規模
- 吸入器投与の市場規模

・世界のジェネリック医薬品市場規模：種類別
- 低分子ジェネリック医薬品の市場規模
- バイオシミラーの市場規模

・顧客状況

・地域別状況
- 北米のジェネリック医薬品市場規模
- ヨーロッパのジェネリック医薬品市場規模
- アジア太平洋のジェネリック医薬品市場規模
- アメリカのジェネリック医薬品市場規模
- ドイツのジェネリック医薬品市場規模
- 中国のジェネリック医薬品市場規模
- イギリスのジェネリック医薬品市場規模
- インドのジェネリック医薬品市場規模
-その他地域のジェネリック医薬品市場規模

・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターの分析によって得られた複数のソースからのデータを、調査・統合・総括することにより、市場の全体像を詳しく提示します。主要な業界のインフルエンサーを特定することにより、多様な市場の側面を提供します。これらのデータは包括的​​で信頼性が高く、一次・二次の広範な研究の結果です。Technavio社の市場調査書は、確かな市場の成長を予測するための定性的、定量的調査を行い、完全な競争状況、そして詳細なベンダー選択方法と分析を提供します。

ジェネリック医薬品の世界市場 2023-2027

Technavio社はジェネリック医薬品市場をモニターしており、2023年から2027年の間に1,762.5億ドルの成長が見込まれ、予測期間中のCAGRは7.11%で加速すると予測しています。当レポートでは、ジェネリック医薬品市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。

現在の世界市場のシナリオ、最新動向と促進要因、市場全体の環境に関する最新分析を提供しています。市場を牽引するのは、低コストの代替品、創薬開発のアウトソーシングの増加、医薬品の特許切れの増加です。

Technavio社のジェネリック医薬品市場は以下のように区分されています：

・投与経路別：
– 経口剤
– 注射剤
– 外用薬
– 吸入薬

・タイプ別：
– 低分子ジェネリック
– バイオシミラー

・地域別：
– 北米
– ヨーロッパ
– アジア
– その他の地域（ROW）

本調査では、RPAの登場が今後数年間のジェネリック医薬品市場の成長を牽引する主な要因の1つであると分析しています。また、M&Aや病院が所有するジェネリック医薬品の増加は、市場の大きな需要につながるでしょう。

Technavioは、複数の情報源からのデータを調査、統合、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

ジェネリック医薬品市場に関する弊社のレポートは以下の分野をカバーしています：
– ジェネリック医薬品市場の規模
– ジェネリック医薬品市場予測
– ジェネリック医薬品市場の業界分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Abbott Laboratories, Amgen Inc., Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., Viatris Inc., Sun Pharmaceutical Industries Ltd., Lupin Ltd., Cadila Pharmaceuticals Ltd., and Cipla Ltdなどの企業情報が含まれています。また、ジェネリック医薬品市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global generic drugs market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global generic drugs market 2017 – 2021 ($ billion)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ billion)
o 4.3 Route of administration Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Route of administration Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Small-molecule generics – Market size and forecast 2022-2027
o Exhibit 34: Chart on Small-molecule generics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Small-molecule generics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Small-molecule generics – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Small-molecule generics – Year-over-year growth 2022-2027 (%)
o 6.4 Biosimilars – Market size and forecast 2022-2027
o Exhibit 38: Chart on Biosimilars – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Biosimilars – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Biosimilars – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Biosimilars – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ billion)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 43: Chart on Route of Administration – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Route of Administration – Market share 2022-2027 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 45: Chart on Comparison by Route of Administration
o Exhibit 46: Data Table on Comparison by Route of Administration
o 7.3 Oral – Market size and forecast 2022-2027
o Exhibit 47: Chart on Oral – Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Data Table on Oral – Market size and forecast 2022-2027 ($ billion)
o Exhibit 49: Chart on Oral – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Oral – Year-over-year growth 2022-2027 (%)
o 7.4 Injectables – Market size and forecast 2022-2027
o Exhibit 51: Chart on Injectables – Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Data Table on Injectables – Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Chart on Injectables – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Injectables – Year-over-year growth 2022-2027 (%)
o 7.5 Topical – Market size and forecast 2022-2027
o Exhibit 55: Chart on Topical – Market size and forecast 2022-2027 ($ billion)
o Exhibit 56: Data Table on Topical – Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Chart on Topical – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Topical – Year-over-year growth 2022-2027 (%)
o 7.6 Inhalers – Market size and forecast 2022-2027
o Exhibit 59: Chart on Inhalers – Market size and forecast 2022-2027 ($ billion)
o Exhibit 60: Data Table on Inhalers – Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Chart on Inhalers – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Inhalers – Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Route of Administration
o Exhibit 63: Market opportunity by Route of Administration ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 67: Chart on Geographic comparison
o Exhibit 68: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 69: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 71: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 73: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 75: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 77: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 78: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 79: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 81: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 82: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 83: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 85: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 86: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 87: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 89: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 90: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 91: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 93: Chart on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 94: Data Table on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 95: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 97: Chart on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 98: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 99: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 India – Market size and forecast 2022-2027
o Exhibit 101: Chart on India – Market size and forecast 2022-2027 ($ billion)
o Exhibit 102: Data Table on India – Market size and forecast 2022-2027 ($ billion)
o Exhibit 103: Chart on India – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on India – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 105: Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 106: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 108: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 109: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 110: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 111: Matrix on vendor position and classification
o 12.3 Amgen Inc.
o Exhibit 112: Amgen Inc. – Overview
o Exhibit 113: Amgen Inc. – Product / Service
o Exhibit 114: Amgen Inc. – Key offerings
o 12.4 Aurobindo Pharma Ltd.
o Exhibit 115: Aurobindo Pharma Ltd. – Overview
o Exhibit 116: Aurobindo Pharma Ltd. – Product / Service
o Exhibit 117: Aurobindo Pharma Ltd. – Key offerings
o 12.5 Baxter International Inc.
o Exhibit 118: Baxter International Inc. – Overview
o Exhibit 119: Baxter International Inc. – Business segments
o Exhibit 120: Baxter International Inc. – Key news
o Exhibit 121: Baxter International Inc. – Key offerings
o Exhibit 122: Baxter International Inc. – Segment focus
o 12.6 Biocon Ltd.
o Exhibit 123: Biocon Ltd. – Overview
o Exhibit 124: Biocon Ltd. – Business segments
o Exhibit 125: Biocon Ltd. – Key offerings
o Exhibit 126: Biocon Ltd. – Segment focus
o 12.7 Cadila Pharmaceuticals Ltd.
o Exhibit 127: Cadila Pharmaceuticals Ltd. – Overview
o Exhibit 128: Cadila Pharmaceuticals Ltd. – Product / Service
o Exhibit 129: Cadila Pharmaceuticals Ltd. – Key offerings
o 12.8 Cipla Ltd.
o Exhibit 130: Cipla Ltd. – Overview
o Exhibit 131: Cipla Ltd. – Business segments
o Exhibit 132: Cipla Ltd. – Key news
o Exhibit 133: Cipla Ltd. – Key offerings
o Exhibit 134: Cipla Ltd. – Segment focus
o 12.9 Dr Reddys Laboratories Ltd.
o Exhibit 135: Dr Reddys Laboratories Ltd. – Overview
o Exhibit 136: Dr Reddys Laboratories Ltd. – Business segments
o Exhibit 137: Dr Reddys Laboratories Ltd. – Key offerings
o Exhibit 138: Dr Reddys Laboratories Ltd. – Segment focus
o 12.10 Fresenius SE and Co. KGaA
o Exhibit 139: Fresenius SE and Co. KGaA – Overview
o Exhibit 140: Fresenius SE and Co. KGaA – Business segments
o Exhibit 141: Fresenius SE and Co. KGaA – Key news
o Exhibit 142: Fresenius SE and Co. KGaA – Key offerings
o Exhibit 143: Fresenius SE and Co. KGaA – Segment focus
o 12.11 Merck and Co. Inc.
o Exhibit 144: Merck and Co. Inc. – Overview
o Exhibit 145: Merck and Co. Inc. – Business segments
o Exhibit 146: Merck and Co. Inc. – Key news
o Exhibit 147: Merck and Co. Inc. – Key offerings
o Exhibit 148: Merck and Co. Inc. – Segment focus
o 12.12 Novartis AG
o Exhibit 149: Novartis AG – Overview
o Exhibit 150: Novartis AG – Business segments
o Exhibit 151: Novartis AG – Key offerings
o Exhibit 152: Novartis AG – Segment focus
o 12.13 Pfizer Inc.
o Exhibit 153: Pfizer Inc. – Overview
o Exhibit 154: Pfizer Inc. – Product / Service
o Exhibit 155: Pfizer Inc. – Key news
o Exhibit 156: Pfizer Inc. – Key offerings
o 12.14 Sanofi SA
o Exhibit 157: Sanofi SA – Overview
o Exhibit 158: Sanofi SA – Business segments
o Exhibit 159: Sanofi SA – Key news
o Exhibit 160: Sanofi SA – Key offerings
o Exhibit 161: Sanofi SA – Segment focus
o 12.15 Sun Pharmaceutical Industries Ltd.
o Exhibit 162: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 163: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 164: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 165: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 166: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 167: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 168: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 169: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Viatris Inc.
o Exhibit 170: Viatris Inc. – Overview
o Exhibit 171: Viatris Inc. – Business segments
o Exhibit 172: Viatris Inc. – Key offerings
o Exhibit 173: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 174: Inclusions checklist
o Exhibit 175: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 176: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 177: Research methodology
o Exhibit 178: Validation techniques employed for market sizing
o Exhibit 179: Information sources
o 13.5 List of abbreviations
o Exhibit 180: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global generic drugs market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – Route of administration Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Small-molecule generics – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Small-molecule generics – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Small-molecule generics – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Small-molecule generics – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Biosimilars – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Biosimilars – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Biosimilars – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Biosimilars – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ billion)
Exhibits43: Chart on Route of Administration – Market share 2022-2027 (%)
Exhibits44: Data Table on Route of Administration – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Route of Administration
Exhibits46: Data Table on Comparison by Route of Administration
Exhibits47: Chart on Oral – Market size and forecast 2022-2027 ($ billion)
Exhibits48: Data Table on Oral – Market size and forecast 2022-2027 ($ billion)
Exhibits49: Chart on Oral – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Oral – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Injectables – Market size and forecast 2022-2027 ($ billion)
Exhibits52: Data Table on Injectables – Market size and forecast 2022-2027 ($ billion)
Exhibits53: Chart on Injectables – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Injectables – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Topical – Market size and forecast 2022-2027 ($ billion)
Exhibits56: Data Table on Topical – Market size and forecast 2022-2027 ($ billion)
Exhibits57: Chart on Topical – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Topical – Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Inhalers – Market size and forecast 2022-2027 ($ billion)
Exhibits60: Data Table on Inhalers – Market size and forecast 2022-2027 ($ billion)
Exhibits61: Chart on Inhalers – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Inhalers – Year-over-year growth 2022-2027 (%)
Exhibits63: Market opportunity by Route of Administration ($ billion)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits70: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits71: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits74: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits75: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits78: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits79: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits82: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits83: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits86: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits87: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits90: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits91: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China – Market size and forecast 2022-2027 ($ billion)
Exhibits94: Data Table on China – Market size and forecast 2022-2027 ($ billion)
Exhibits95: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits98: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits99: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on India – Market size and forecast 2022-2027 ($ billion)
Exhibits102: Data Table on India – Market size and forecast 2022-2027 ($ billion)
Exhibits103: Chart on India – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on India – Year-over-year growth 2022-2027 (%)
Exhibits105: Market opportunity By Geographical Landscape ($ billion)
Exhibits106: Impact of drivers and challenges in 2022 and 2027
Exhibits107: Overview on Criticality of inputs and Factors of differentiation
Exhibits108: Overview on factors of disruption
Exhibits109: Impact of key risks on business
Exhibits110: Vendors covered
Exhibits111: Matrix on vendor position and classification
Exhibits112: Amgen Inc. – Overview
Exhibits113: Amgen Inc. – Product / Service
Exhibits114: Amgen Inc. – Key offerings
Exhibits115: Aurobindo Pharma Ltd. – Overview
Exhibits116: Aurobindo Pharma Ltd. – Product / Service
Exhibits117: Aurobindo Pharma Ltd. – Key offerings
Exhibits118: Baxter International Inc. – Overview
Exhibits119: Baxter International Inc. – Business segments
Exhibits120: Baxter International Inc. – Key news
Exhibits121: Baxter International Inc. – Key offerings
Exhibits122: Baxter International Inc. – Segment focus
Exhibits123: Biocon Ltd. – Overview
Exhibits124: Biocon Ltd. – Business segments
Exhibits125: Biocon Ltd. – Key offerings
Exhibits126: Biocon Ltd. – Segment focus
Exhibits127: Cadila Pharmaceuticals Ltd. – Overview
Exhibits128: Cadila Pharmaceuticals Ltd. – Product / Service
Exhibits129: Cadila Pharmaceuticals Ltd. – Key offerings
Exhibits130: Cipla Ltd. – Overview
Exhibits131: Cipla Ltd. – Business segments
Exhibits132: Cipla Ltd. – Key news
Exhibits133: Cipla Ltd. – Key offerings
Exhibits134: Cipla Ltd. – Segment focus
Exhibits135: Dr Reddys Laboratories Ltd. – Overview
Exhibits136: Dr Reddys Laboratories Ltd. – Business segments
Exhibits137: Dr Reddys Laboratories Ltd. – Key offerings
Exhibits138: Dr Reddys Laboratories Ltd. – Segment focus
Exhibits139: Fresenius SE and Co. KGaA – Overview
Exhibits140: Fresenius SE and Co. KGaA – Business segments
Exhibits141: Fresenius SE and Co. KGaA – Key news
Exhibits142: Fresenius SE and Co. KGaA – Key offerings
Exhibits143: Fresenius SE and Co. KGaA – Segment focus
Exhibits144: Merck and Co. Inc. – Overview
Exhibits145: Merck and Co. Inc. – Business segments
Exhibits146: Merck and Co. Inc. – Key news
Exhibits147: Merck and Co. Inc. – Key offerings
Exhibits148: Merck and Co. Inc. – Segment focus
Exhibits149: Novartis AG – Overview
Exhibits150: Novartis AG – Business segments
Exhibits151: Novartis AG – Key offerings
Exhibits152: Novartis AG – Segment focus
Exhibits153: Pfizer Inc. – Overview
Exhibits154: Pfizer Inc. – Product / Service
Exhibits155: Pfizer Inc. – Key news
Exhibits156: Pfizer Inc. – Key offerings
Exhibits157: Sanofi SA – Overview
Exhibits158: Sanofi SA – Business segments
Exhibits159: Sanofi SA – Key news
Exhibits160: Sanofi SA – Key offerings
Exhibits161: Sanofi SA – Segment focus
Exhibits162: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits163: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits164: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits165: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits166: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits167: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits168: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits169: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits170: Viatris Inc. – Overview
Exhibits171: Viatris Inc. – Business segments
Exhibits172: Viatris Inc. – Key offerings
Exhibits173: Viatris Inc. – Segment focus
Exhibits174: Inclusions checklist
Exhibits175: Exclusions checklist
Exhibits176: Currency conversion rates for US$
Exhibits177: Research methodology
Exhibits178: Validation techniques employed for market sizing
Exhibits179: Information sources
Exhibits180: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のジェネリック医薬品市場2023-2030：一般ジェネリック、特殊ジェネリック、バイオシミラー
  • 電子顕微鏡のグローバル市場2023-2027：半導体、ライフサイエンス、材料科学、ナノテクノロジー
  • コロナウイルス検査キットの世界市場2023～2027
  • 神経調節のグローバル市場2023-2027：埋め込み型神経調節装置、体外式神経調節装置
  • 行動リハビリテーションの世界市場2023～2027
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IRTNTR44584-23 )"世界のジェネリック医薬品市場2023～2027：経口、注射、座薬(外用)、吸入器" (英文：Global Generic drugs Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。